e-learning
resources
London 2016
Monday, 05.09.2016
Prevalence, prognosis, and risk factors of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Modelling the long-term effects of an active case finding programme for undiagnosed COPD
Tosin Lambe (Birmingham, United Kingdom), Tosin Lambe, Rachel Jordan, Peymane Adab, David Fitzmaurice, Sue Jowett, Alexandra Enocson
Source:
International Congress 2016 – Prevalence, prognosis, and risk factors of COPD
Session:
Prevalence, prognosis, and risk factors of COPD
Session type:
Poster Discussion
Number:
3113
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Tosin Lambe (Birmingham, United Kingdom), Tosin Lambe, Rachel Jordan, Peymane Adab, David Fitzmaurice, Sue Jowett, Alexandra Enocson. Modelling the long-term effects of an active case finding programme for undiagnosed COPD. Eur Respir J 2016; 48: Suppl. 60, 3113
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Short-term evaluation of a remote patient support program in patients with COPD and frequent exacerbations. ESOPO study
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015
Longitudinal changes in COPD patients in primary care
Source: International Congress 2016 – In-patient and out-patient COPD management
Year: 2016
Reduction in clinically important deterioration in COPD with aclidinium/formoterol
Source: International Congress 2016 – Pharmacological management of COPD
Year: 2016
Implementation of COPD phenotypes in real life
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015
Loneliness and lack of social support severely influences patients’ quality of life. Secondary findings from our focusgroup study in asthma and COPD patients
Source: International Congress 2016 – Best abstracts in COPD management
Year: 2016
Discordant symptom severity in COPD: The PHAROAH study
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015
Health status predicts long-term outcomes in patients with chronic obstructive pulmonary disease (COPD): Pooled analysis of patient-level data from the COPD biomarker qualification consortium database
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015
Do patients with COPD who live alone present better functional status than those who do not?
Source: International Congress 2015 – Respiratory physiotherapy assessment and techniques in COPD and asthma
Year: 2015
The pulmonary artery-aorta ratio, exacerbation rate and quality of life in stable COPD patients
Source: International Congress 2016 – Exploring mechanisms in health and disease
Year: 2016
Impact of lung function impairment and exacerbation history on COPD patient-reported utility
Source: International Congress 2014 – COPD markers
Year: 2014
The prevalence of comorbidities in COPD patients and their impact on quality of life and COPD symptoms in primary care patients - An UNLOCK study from the IPCRG
Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care
Year: 2016
Impaired health status in primary care COPD patients is underestimated
Source: International Congress 2015 – Respiratory disease management in primary care
Year: 2015
Determination of the existence of a correlation between lung function decline and changes in the COPD assessment test
Source: International Congress 2014 – Clinical presentations
Year: 2014
On-line survey of a 7 steps patient passport for COPD
Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations
Year: 2013
Measurement of COPD’s impact using the COPD assessment test (CAT) and symptom assessment differences between patients and family members
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013
What influences change in health status in COPD in a seven year follow-up?
Source: International Congress 2015 – Respiratory disease management in primary care
Year: 2015
Change in the COPD assessment test (CAT) score as predictor of short-term evolution of patients admitted for an exacerbation of COPD
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
What should be part of a comprehensive assessment of COPD?
Source: International Congress 2016 – Best abstracts in COPD management
Year: 2016
The impact of exacerbations on adherence and outcomes of pulmonary rehabilitation in patients with COPD
Source: International Congress 2016 – Management of dyspnoea and exacerbations in chronic lung diseases
Year: 2016
COPD assessment for symptoms and functional condition in pulmonary rehabilitation
Source: International Congress 2015 – Functional capacity, exercise and pulmonary rehabilitation in chronic lung diseases
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept